Overexpression of TROP2 promotes proliferation and invasion of ovarian cancer cells

Experimental and Therapeutic Medicine

Volumn 14, Issue 3, 2017, Pages 1947-1952

  Wu, Bin ^a,b   Yu, Chunli ^b   Zhou, Bin ^b   Huang, Tingting ^b   Gao, Lei ^b   Liu, Tao ^b   Yang, Xingsheng ^a  

^a SHANDONG UNIVERSITY   (China)

^b TAIAN CITY CENTRAL HOSPITAL   (China)

Author keywords

Migration; Ovarian cancer; Proliferation; Small interfering RNA; Tumor associated calcium signal transducer 2

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; TUMOR ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2; TUMOR MARKER; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL INVASION; CELL INVASION ASSAY; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; OVARIAN CANCER CELL LINE; OVARY CARCINOMA; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING ASSAY;

EID: 85026678598     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.4788     Document Type: Article

References (19)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. Cannistra SA: Cancer of the ovary. N Engl J Med 351: 2519-2529, 2004.
3. Auersperg N, Ota T and Mitchell GW: Early events in ovarian epithelial carcinogenesis: Progress and problems in experimental approaches. Int J Gynecol Cancer 12: 691-703, 2002.
4. Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M and Laimer K: TROP2: A novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 21: 186-191, 2008.
5. Shvartsur A and Bonavida B: Trop2 and its overexpression in cancers: Regulation and clinical/therapeutic implications. Genes Cancer 6: 84-105, 2015.
6. Bignotti E, Zanotti L, Calza S, Falchetti M, Lonardi S, Ravaggi A, Romani C, Todeschini P, Bandiera E, Tassi RA, et al: Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma. BMC Clin Pathol 12: 22, 2012.
7. Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S and Geradts J: Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Clin Cancer Res 11: 4357-4364, 2005.
8. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K and Mori M: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063, 2006.
9. Bignotti E, Ravaggi A, Romani C, Falchetti M, Lonardi S, Facchetti F, Pecorelli S, Varughese J, Cocco E, Bellone S, et al: Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: Implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody. Int J Gynecol Cancer 21: 1613-1621, 2011.
10. Varughese J, Cocco E, Bellone S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Buza N, Pecorelli S and Santin AD: Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Am J Obstet Gynecol 205: 567.e1-7, 2011.
11. Wang XD, Wang Q, Chen XL, Huang JF, Yin Y, Da P and Wu H: Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway. Mol Med Rep 12: 865-870, 2015.
12. Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, et al: Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer 46: 944-953, 2010.
13. Varughese J, Cocco E, Bellone S, Bellone M, Todeschini P, Carrara L, Schwartz PE, Rutherford TJ, Pecorelli S and Santin AD: High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Gynecol Oncol 122: 171-177, 2011.
14. Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, et al: Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer 46: 944-953, 2010.
15. Chen CR, Xia YH, Yao SY, Zhang Q, Wang Y and Ji ZN: Virosecurinine induces apoptosis by affecting Bcl-2 and Bax expression in human colon cancer SW480 cells. Pharmazie 67: 351-354, 2012.
16. Jordan S, Green A and Webb P: Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk? Cancer Causes Control 17: 623-632, 2006.
17. Ripani E, Sacchetti A, Corda D and Alberti S: Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 76: 671-676, 1998.
18. Fornaro M, Dell'Arciprete R, Stella M, Bucci C, Nutini M, Capri MG and Alberti S: Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 62: 610-618, 1995.
19. Domcke S, Sinha R, Levine DA, Sander C and Schultz N: Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun 4: 2126, 2013.